SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-22-009863
Filing Date
2022-04-14
Accepted
2022-04-13 19:44:04
Documents
65
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 1179557
2 ex31-1.htm EX-31.1 14854
3 ex31-2.htm EX-31.2 15117
4 ex32-1.htm EX-32.1 8663
5 form10-k_001.jpg GRAPHIC 3815
6 form10-ka_002.jpg GRAPHIC 90817
7 form10-ka_003.jpg GRAPHIC 113149
8 form10-ka_004.jpg GRAPHIC 36528
  Complete submission text file 0001493152-22-009863.txt   4640866

Data Files

Seq Description Document Type Size
9 INLINE XBRL INSTANCE DOCUMENT crxm-20201231.xml EX-101.INS 581459
10 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crxm-20201231.xsd EX-101.SCH 39885
11 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crxm-20201231_cal.xml EX-101.CAL 58022
12 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crxm-20201231_def.xml EX-101.DEF 174496
13 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crxm-20201231_lab.xml EX-101.LAB 305510
14 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crxm-20201231_pre.xml EX-101.PRE 254526
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33635 | Film No.: 22825725
SIC: 2836 Biological Products, (No Diagnostic Substances)